The biotin-conjugated Fe(III) catecholate complex [Fe(BioL)], Fe(BioL) (BioLH=N-(3,4-dihydroxyphenethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide) is reported as targeted magnetic resonance imaging (MRI) contrast agents (CAs) to increase the payload for early-stage imaging of tumours. The high spin state and octahedral coordination of the Fe(III) complex are confirmed by EPR spectra and DFT optimized structure, respectively. The overall formation constant (log K) of Fe(BioL) is determined as 45, which is higher than the known, more stable complex [Fe(EDTA)].
View Article and Find Full Text PDFThe C-alkyl chain-conjugated Fe(III) catecholate complex [Fe(CCAT)], () [CCAT = -(3,4-dihydroxyphenethyl)dodecanamide], was synthesized and characterized, reported as a dual-modal -MRI and an optical imaging probe. The DFT-optimized structure of reveals a distorted octahedral coordination geometry around the high spin Fe(III) center. The formation constant (-log K) of was calculated as 45.
View Article and Find Full Text PDFA rhodamine appended Fe(iii)-catecholate complex Fe(RhoCat)3 is reported as a smart dual-modal T1 MRI-optical imaging probe. The high spin Fe(iii) coordination sphere and rhodamine unit act as MRI and optical reporters, respectively. The probe showed a r1-relaxivity of 4.
View Article and Find Full Text PDFCopper(ii) complexes [Cu(L1)(HO)](SOCF)1 and [Cu(L2)(HO)](SOCF)2 based on 2,6-bis(benzimidazolyl)pyridine were synthesized and are reported herein as highly selective "turn-on" optical probes for l-cysteine. The Cu(ii)/Cu(i) redox potential of probe 1 (0.14 V vs.
View Article and Find Full Text PDF